APA (7th ed.) Citation

Degering, J., Egenlauf, B., Harutyunova, S., Benjamin, N., Salkić, A., Xanthouli, P., . . . Grünig, E. (2023). Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): A prospective, 6-months, open label, observational, non-interventional study. Respiratory research, 24, . https://doi.org/10.1186/s12931-022-02296-z

Chicago Style (17th ed.) Citation

Degering, Julia, et al. "Tolerability, Safety and Survival in Patients with Severe Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol (Veletri®): A Prospective, 6-months, Open Label, Observational, Non-interventional Study." Respiratory Research 24 (2023). https://doi.org/10.1186/s12931-022-02296-z.

MLA (9th ed.) Citation

Degering, Julia, et al. "Tolerability, Safety and Survival in Patients with Severe Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol (Veletri®): A Prospective, 6-months, Open Label, Observational, Non-interventional Study." Respiratory Research, vol. 24, 2023, https://doi.org/10.1186/s12931-022-02296-z.